Amira Permatasari Tarigan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amira Permatasari Tarigan has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Pandiaman Pandia
Methodist Indonesia University
13 shared publications- Andika Pradana
Universitas Sumatera Utara
8 shared publications - Putri Chairani Eyanoer
Universitas Sumatera Utara, Indonesia
6 shared publications Maryaningsih Maryaningsih
Faculty of Physiotherapy, Sekolah Tinggi Ilmu Kesehatan Siti Hajar, Medan, Indonesia
4 shared publicationsAndika Pradana
Division of Asthma-COPD, Department of Pulmonology and Respiratory Medicine Faculty of Medicine, Universitas Sumatera Utara, Medan
3 shared publications- Benny Sihombing
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, 20155, Indonesia
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Coinreads in Journal of Society Medicine
- Vol. 5 (7) , 248-252
The Benefit of Application-Based Education Using the Healthy Lungs Version 2.0 on Inhaler Adherence Among Patients with Chronic Obstructive Pulmonary Disease at RS Prof. Dr. Chairuddin P. Lubis
Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Inhalation therapy is central to management; however, suboptimal adherence and incorrect inhaler technique contribute to poor disease control and recurrent exacerbations. Application-based education provides continuous, standardized, accessible instruction that may improve adherence to inhaler therapy. The Healthy Lungs application 2.0 was developed in the Philippines for COPD patients to evaluate its educational effectiveness on inhaler adherence at RS Prof. Dr. Chairuddin P. Lubis, University of North Sumatra, Indonesia. Methods: An analytical study with a case–control approach enrolled 50 patients with COPD selected by consecutive sampling. Inhaler adherence was assessed with a structured questionnaire before and after the application-based intervention. Normality was examined with the Kolmogorov–Smirnov test, and pre- versus post-intervention adherence was compared using the Wilcoxon signed-rank test, with significance set at p < 0.05. Results: The respondents were predominantly elderly (43%) and male (58%). Before the intervention, low adherence predominated (50%); afterwards, the proportion with high adherence rose to 42%, with most respondents improving and few declining. The Wilcoxon test demonstrated a significant difference in adherence before and after the intervention (Z = –3.196; p = 0.001), with a large effect size (Cohen's d = 1.05). Conclusion: Education delivered through the Healthy Lungs app significantly improved inhaler adherence among patients with COPD, supporting its use as an adjunct to conventional inhaler counseling.
- 29 July 2026
- Published by Coinreads in Journal of Society Medicine
- Vol. 5 (7) , 248-252
Open AccessThe Benefit of Application-Based Education Using the Healthy Lungs Version 2.0 on Inhaler Adherence Among Patients with Chronic Obstructive Pulmonary Disease at RS Prof. Dr. Chairuddin P. Lubis
Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Inhalation therapy is central to management; however, suboptimal adherence and incorrect inhaler technique contribute to poor disease control and recurrent exacerbations. Application-based education provides continuous, standardized, accessible instruction that may improve adherence to inhaler therapy. The Healthy Lungs application 2.0 was developed in the Philippines for COPD patients to evaluate its educational effectiveness on inhaler adherence at RS Prof. Dr. Chairuddin P. Lubis, University of North Sumatra, Indonesia. Methods: An analytical study with a case–control approach enrolled 50 patients with COPD selected by consecutive sampling. Inhaler adherence was assessed with a structured questionnaire before and after the application-based intervention. Normality was examined with the Kolmogorov–Smirnov test, and pre- versus post-intervention adherence was compared using the Wilcoxon signed-rank test, with significance set at p < 0.05. Results: The respondents were predominantly elderly (43%) and male (58%). Before the intervention, low adherence predominated (50%); afterwards, the proportion with high adherence rose to 42%, with most respondents improving and few declining. The Wilcoxon test demonstrated a significant difference in adherence before and after the intervention (Z = –3.196; p = 0.001), with a large effect size (Cohen's d = 1.05). Conclusion: Education delivered through the Healthy Lungs app significantly improved inhaler adherence among patients with COPD, supporting its use as an adjunct to conventional inhaler counseling.
- Open Access
- 11 November 2025
- Published by CV. Afdifal Maju Berkah in International Journal of Health Engineering and Technology
- Vol. 4 (4)
Overview Of Asthma Control Test (Act) And Lung Function in Asthma Patients at Tanjungpura General Hospital
Asthma represents one of the most significant chronic respiratory disorders globally, affecting approximately 300 million individuals worldwide and imposing substantial morbidity, mortality, and healthcare costs. Despite advances in therapeutic interventions, achieving optimal disease control remains challenging, with only 15% of patients achieving good control globally. This study aimed to provide a comprehensive overview of asthma control using the Asthma Control Test (ACT) and pulmonary function assessment in asthma patients at Tanjungpura General Hospital. A descriptive observational cross-sectional study was conducted in March 2024 involving 54 asthma patients selected through consecutive sampling technique. Data collection utilized validated instruments including ACT questionnaire, spirometry following ATS/ERS guidelines, and peak expiratory flow measurements, with analysis employing descriptive statistical methods. Results revealed female predominance (64.8%), with the majority aged 18-60 years (83.3%) and housewives as the most common occupation (46.2%). Critically, 88.9% of patients exhibited uncontrolled asthma based on ACT scores, with moderate obstruction being the most frequent spirometric pattern (42.6%). Moderate persistent asthma was predominant (53.7%), and salmeterol xinafoate-fluticasone propionate combination was the most prescribed medication (90.7%). The study concludes that suboptimal asthma control is prevalent, emphasizing the urgent need for comprehensive management strategies integrating regular monitoring, enhanced patient education, and individualized treatment approaches to optimize clinical outcomes.
- 11 November 2025
- Published by CV. Afdifal Maju Berkah in International Journal of Health Engineering and Technology
- Vol. 4 (4)
Open AccessOverview Of Asthma Control Test (Act) And Lung Function in Asthma Patients at Tanjungpura General Hospital
Asthma represents one of the most significant chronic respiratory disorders globally, affecting approximately 300 million individuals worldwide and imposing substantial morbidity, mortality, and healthcare costs. Despite advances in therapeutic interventions, achieving optimal disease control remains challenging, with only 15% of patients achieving good control globally. This study aimed to provide a comprehensive overview of asthma control using the Asthma Control Test (ACT) and pulmonary function assessment in asthma patients at Tanjungpura General Hospital. A descriptive observational cross-sectional study was conducted in March 2024 involving 54 asthma patients selected through consecutive sampling technique. Data collection utilized validated instruments including ACT questionnaire, spirometry following ATS/ERS guidelines, and peak expiratory flow measurements, with analysis employing descriptive statistical methods. Results revealed female predominance (64.8%), with the majority aged 18-60 years (83.3%) and housewives as the most common occupation (46.2%). Critically, 88.9% of patients exhibited uncontrolled asthma based on ACT scores, with moderate obstruction being the most frequent spirometric pattern (42.6%). Moderate persistent asthma was predominant (53.7%), and salmeterol xinafoate-fluticasone propionate combination was the most prescribed medication (90.7%). The study concludes that suboptimal asthma control is prevalent, emphasizing the urgent need for comprehensive management strategies integrating regular monitoring, enhanced patient education, and individualized treatment approaches to optimize clinical outcomes.
- Open Access
- 1 September 2025
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 52 (3) , 32-37
Change of VO 2 Max and Muscle Mass After One-Month and Two-Month Upper and Lower Body Exercises in Stable Chronic Obstructive Pulmonary Disease
Background: Skeletal muscle dysfunction inevitably occurs due to systemic inflammation of Chronic Obstructive Pulmonary Disease (COPD), which manifests as muscle atrophy and dysfunction. It also exhibits decreases in muscle strength and endurance, leading to a deconditioned state and a reduction in maximal oxygen uptake (VO 2 max) in tissues. Exercise training can increase VO 2 max value. The main purpose of this study is to evaluate the benefits and compare the effectiveness of upper and lower body exercises given for one to two months in stable COPD patients. Methods: This quasi-experimental study was conducted on 25 stable COPD patients from December 2018 to May 2019 at the Physiotherapy Unit of Siti Hajar Hospital, Medan, Indonesia. All participants performed upper-body exercises and stationary bicycles for lower-body exercises twice a week for one month, then continued for two additional months. VO 2 max was calculated using the Nury Formula, specially developed for the Indonesian population, while muscle mass values were assessed using the OMRON Karada Scan scales. VO 2 max and muscle mass were measured before training (baseline) after one-month and two-month training. The statistical analysis used is the Repeated ANOVA test. Results: The baseline of mean muscle mass in COPD patients was 28.8 ± 2.43%. Muscle mass increased to 29.1 ± 2.34% in one month and 29.5 ± 3.01% after two months (p < 0.05). The mean value of VO 2 max before doing upper and low body exercises was 21.0 ± 3.08%. VO 2 was significantly increased after two-month training to 23.0 ± 3.6% (p < 0.001), but not after one-month training (VO 2 max: 21.32 ± 3.22%; (p < 0.001). Conclusion: Two-month upper and lower body training provides a greater impact in improving VO 2 max and muscle mass in stable COPD patients.
- 1 September 2025
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 52 (3) , 32-37
Open AccessChange of VO 2 Max and Muscle Mass After One-Month and Two-Month Upper and Lower Body Exercises in Stable Chronic Obstructive Pulmonary Disease
Background: Skeletal muscle dysfunction inevitably occurs due to systemic inflammation of Chronic Obstructive Pulmonary Disease (COPD), which manifests as muscle atrophy and dysfunction. It also exhibits decreases in muscle strength and endurance, leading to a deconditioned state and a reduction in maximal oxygen uptake (VO 2 max) in tissues. Exercise training can increase VO 2 max value. The main purpose of this study is to evaluate the benefits and compare the effectiveness of upper and lower body exercises given for one to two months in stable COPD patients. Methods: This quasi-experimental study was conducted on 25 stable COPD patients from December 2018 to May 2019 at the Physiotherapy Unit of Siti Hajar Hospital, Medan, Indonesia. All participants performed upper-body exercises and stationary bicycles for lower-body exercises twice a week for one month, then continued for two additional months. VO 2 max was calculated using the Nury Formula, specially developed for the Indonesian population, while muscle mass values were assessed using the OMRON Karada Scan scales. VO 2 max and muscle mass were measured before training (baseline) after one-month and two-month training. The statistical analysis used is the Repeated ANOVA test. Results: The baseline of mean muscle mass in COPD patients was 28.8 ± 2.43%. Muscle mass increased to 29.1 ± 2.34% in one month and 29.5 ± 3.01% after two months (p < 0.05). The mean value of VO 2 max before doing upper and low body exercises was 21.0 ± 3.08%. VO 2 was significantly increased after two-month training to 23.0 ± 3.6% (p < 0.001), but not after one-month training (VO 2 max: 21.32 ± 3.22%; (p < 0.001). Conclusion: Two-month upper and lower body training provides a greater impact in improving VO 2 max and muscle mass in stable COPD patients.
- Open Access
- 30 January 2025
- Published by Universitas Airlangga in Jurnal Respirasi
- Vol. 11 (1) , 54-61
Deterioration of Respiratory Symptoms in Uncontrolled CPFE: A Case Report
Introduction: Chronic obstructive pulmonary disease (COPD) has a global impact on health and increases healthcare costs. Combined pulmonary fibrosis and emphysema (CPFE) combines interstitial lung disease (ILD) and emphysema. Excessive short-acting β2-agonist (SABA) usage escalates exacerbation risk, affecting prognosis. Case: A 44-year-old former smoker presented with worsening shortness of breath, cough, and weight loss. Examination showed respiratory distress, including wheezing. Initially, he was diagnosed with tuberculosis (TB) and COPD exacerbation. He regularly used jet nebulizers without medical supervision, and during the initial treatment, he developed acute respiratory failure, leading to acidosis. Treatment involved SABA and short-acting muscarinic-antagonist (SAMA), steroids, and oxygen therapy. In November 2023, his condition worsened, requiring emergency treatment. Radiological findings indicated CPFE. Management included nebulized medications, intravenous steroids, and antibiotics. Despite challenges, he rarely attended follow-up appointments after showing improvement, missing scheduled rehabilitation therapy, inhaler monitoring, comorbid therapy, and home oxygen monitoring. Conclusion: Combined pulmonary fibrosis and emphysema combines ILD and emphysema, causing severe respiratory impairment. Management mirrors that of COPD, involving inhalers, corticosteroids, and oxygen therapy.
- 30 January 2025
- Published by Universitas Airlangga in Jurnal Respirasi
- Vol. 11 (1) , 54-61
Open AccessDeterioration of Respiratory Symptoms in Uncontrolled CPFE: A Case Report
Introduction: Chronic obstructive pulmonary disease (COPD) has a global impact on health and increases healthcare costs. Combined pulmonary fibrosis and emphysema (CPFE) combines interstitial lung disease (ILD) and emphysema. Excessive short-acting β2-agonist (SABA) usage escalates exacerbation risk, affecting prognosis. Case: A 44-year-old former smoker presented with worsening shortness of breath, cough, and weight loss. Examination showed respiratory distress, including wheezing. Initially, he was diagnosed with tuberculosis (TB) and COPD exacerbation. He regularly used jet nebulizers without medical supervision, and during the initial treatment, he developed acute respiratory failure, leading to acidosis. Treatment involved SABA and short-acting muscarinic-antagonist (SAMA), steroids, and oxygen therapy. In November 2023, his condition worsened, requiring emergency treatment. Radiological findings indicated CPFE. Management included nebulized medications, intravenous steroids, and antibiotics. Despite challenges, he rarely attended follow-up appointments after showing improvement, missing scheduled rehabilitation therapy, inhaler monitoring, comorbid therapy, and home oxygen monitoring. Conclusion: Combined pulmonary fibrosis and emphysema combines ILD and emphysema, causing severe respiratory impairment. Management mirrors that of COPD, involving inhalers, corticosteroids, and oxygen therapy.
- Open Access
- 1 January 2025
- Published by Narra Sains Indonesia in Narra J
- Vol. 5 (1) , e1332
Probiotics-derived butyric acid may suppress systemic inflammation in a murine model of chronic obstructive pulmonary disease (COPD)
Systemic inflammation in chronic obstructive pulmonary disease (COPD) contributes to multimorbidity and a diminished quality of life. Probiotics, through the gut-lung axis, have shown potential to mitigate systemic inflammation; however, their specific role in COPD-related inflammation remains unclear. The aim of this study was to evaluate the efficacy of probiotics in reducing serum interleukin-6 (IL-6) levels by enhancing butyric acid production in a murine model of COPD. An in vivo experimental study with a post-test-only control group design was conducted using 30 C57BL/6 mice randomized into five groups: non-COPD healthy control, untreated COPD, COPD treated with bronchodilator, COPD treated with probiotics, and COPD treated with a combination of bronchodilator and probiotics. COPD was induced by six weeks of cigarette smoke exposure, followed by six weeks of treatment while continuing the smoke exposure. Caecal butyric acid and serum IL-6 levels were measured using enzyme-linked immunosorbent assay (ELISA) and gas chromatography, respectively. Caecal butyric acid levels were lowest in untreated COPD mice (1.2±0.28 mmol/L) and significantly increased with probiotic administration (6.6±4.43 mmol/L, p=0.010), exceeding levels observed in healthy controls (3.9±2.05 mmol/L). Serum IL-6 levels were highest in COPD-induced mice (19.4±6.71 pg/mL) and significantly reduced with administration of probiotics (13.5±0.43 pg/mL, p=0.035), approaching levels of healthy controls (13.0±2.24 pg/mL, p=0.847). A negative correlation was observed between butyric acid and serum IL-6 levels (r=-0.420; p=0.021), suggesting that higher butyric acid levels were associated with reduced systemic inflammation. These findings demonstrated that probiotics, via their metabolite butyric acid, effectively reduced systemic inflammation in a COPD mouse model, highlighting their potential as a therapeutic approach for managing COPD-related inflammation.
- 1 January 2025
- Published by Narra Sains Indonesia in Narra J
- Vol. 5 (1) , e1332
Open AccessProbiotics-derived butyric acid may suppress systemic inflammation in a murine model of chronic obstructive pulmonary disease (COPD)
Systemic inflammation in chronic obstructive pulmonary disease (COPD) contributes to multimorbidity and a diminished quality of life. Probiotics, through the gut-lung axis, have shown potential to mitigate systemic inflammation; however, their specific role in COPD-related inflammation remains unclear. The aim of this study was to evaluate the efficacy of probiotics in reducing serum interleukin-6 (IL-6) levels by enhancing butyric acid production in a murine model of COPD. An in vivo experimental study with a post-test-only control group design was conducted using 30 C57BL/6 mice randomized into five groups: non-COPD healthy control, untreated COPD, COPD treated with bronchodilator, COPD treated with probiotics, and COPD treated with a combination of bronchodilator and probiotics. COPD was induced by six weeks of cigarette smoke exposure, followed by six weeks of treatment while continuing the smoke exposure. Caecal butyric acid and serum IL-6 levels were measured using enzyme-linked immunosorbent assay (ELISA) and gas chromatography, respectively. Caecal butyric acid levels were lowest in untreated COPD mice (1.2±0.28 mmol/L) and significantly increased with probiotic administration (6.6±4.43 mmol/L, p=0.010), exceeding levels observed in healthy controls (3.9±2.05 mmol/L). Serum IL-6 levels were highest in COPD-induced mice (19.4±6.71 pg/mL) and significantly reduced with administration of probiotics (13.5±0.43 pg/mL, p=0.035), approaching levels of healthy controls (13.0±2.24 pg/mL, p=0.847). A negative correlation was observed between butyric acid and serum IL-6 levels (r=-0.420; p=0.021), suggesting that higher butyric acid levels were associated with reduced systemic inflammation. These findings demonstrated that probiotics, via their metabolite butyric acid, effectively reduced systemic inflammation in a COPD mouse model, highlighting their potential as a therapeutic approach for managing COPD-related inflammation.
- Open Access
- 1 September 2024
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 51 (3) , 1-5
Benefits of Upper-Extremity Strength Workout on Muscle and Fat-Free Mass Through Home-Based Lung Rehabilitation in COPD Patients
Background: COPD patients not only experience respiratory problems but can have fatigue, physical limitations and reduced overall quality of life. Pulmonary rehabilitation is the main non-pharmacological solution after pharmacological treatment based on COPD grouping. The main aim of this study is to evaluate the benefits of weight lifting strength training twice a week for 4 weeks for COPD patients using home-based pulmonary rehabilitation. It can be done independently by the patient, is easy to do anywhere and at any time and is free of cost. This can be one of the home-based pulmonary rehabilitation options that can be implemented in the future. Methods: This research was a quasiexperimental study with 10 stable COPD patients. The patients underwent home pulmonary rehabilitation of twice-a-week weight-lifting strength exercises for 4 weeks. They were taught how to do the exercise during the initial visit at the hospital which they continued to do independently at home with the help of an instruction video containing the exercise movements. Muscle and fat-free mass measuring was conducted before and after the intervention. Patients were evaluated using videos which they sent to the researchers. Results: COPD patients who concluded the home-based lung rehabilitation showed increase in muscle mass after the intervention (30.12 ± 3.83 SD, p = 0.017). Fat-free mass did not show any increase (49.13 ± 6.93 SD, p = 0.154). Conclusion: Home pulmonary rehabilitation benefits patients as much as the traditional rehabilitation done at health-care centers. This was proven by the significant increase in muscle mass after the intervention despite no change found in fat-free mass, which could be remedied in the future by giving extra diet to meet patients’ nutrition needs.
- 1 September 2024
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 51 (3) , 1-5
Open AccessBenefits of Upper-Extremity Strength Workout on Muscle and Fat-Free Mass Through Home-Based Lung Rehabilitation in COPD Patients
Background: COPD patients not only experience respiratory problems but can have fatigue, physical limitations and reduced overall quality of life. Pulmonary rehabilitation is the main non-pharmacological solution after pharmacological treatment based on COPD grouping. The main aim of this study is to evaluate the benefits of weight lifting strength training twice a week for 4 weeks for COPD patients using home-based pulmonary rehabilitation. It can be done independently by the patient, is easy to do anywhere and at any time and is free of cost. This can be one of the home-based pulmonary rehabilitation options that can be implemented in the future. Methods: This research was a quasiexperimental study with 10 stable COPD patients. The patients underwent home pulmonary rehabilitation of twice-a-week weight-lifting strength exercises for 4 weeks. They were taught how to do the exercise during the initial visit at the hospital which they continued to do independently at home with the help of an instruction video containing the exercise movements. Muscle and fat-free mass measuring was conducted before and after the intervention. Patients were evaluated using videos which they sent to the researchers. Results: COPD patients who concluded the home-based lung rehabilitation showed increase in muscle mass after the intervention (30.12 ± 3.83 SD, p = 0.017). Fat-free mass did not show any increase (49.13 ± 6.93 SD, p = 0.154). Conclusion: Home pulmonary rehabilitation benefits patients as much as the traditional rehabilitation done at health-care centers. This was proven by the significant increase in muscle mass after the intervention despite no change found in fat-free mass, which could be remedied in the future by giving extra diet to meet patients’ nutrition needs.
- Open Access
- 17 April 2024
- Published by Narra Sains Indonesia in Narra J
- Vol. 4 (2) , e657
Role of digital education through smartphones in improving knowledge among asthma patients: A preliminary study
Asthma is a chronic inflammatory airway disorder and is among the top ten causes of morbidity and mortality in Indonesia, highlighting the need for effective management strategies. This study aimed to evaluate changes in asthma knowledge levels before and after using the "Paru Sehat" smartphone application for digital education. A quasi-experimental study using a pre- and post-test design was conducted over three months at the outpatient clinic of Universitas Sumatera Utara Hospital, Medan, Indonesia, among asthma patients aged over 18 years. The patients completed the Patient Asthma Knowledge Questionnaire (PAKQ) before installing the "Paru Sehat" application to establish baseline knowledge. Once a week, patients received reminders to access materials covering an asthma overview, peak flow meter use, medication differences, and management techniques. After four weeks of intervention, the participants' knowledge was reassessed using the PAKQ. Data were analyzed using either paired Student's t-test or Wilcoxon test to assess the improvement in knowledge. The results showed increases in knowledge about asthma in general, asthma triggers, and asthma diagnosis domains, with the median score in each domain rising by one point (p=0.003, p=0.001, and p=0.002, respectively). The asthma management domain exhibited the largest change, with a median increase of two points (p<0.001). The total scores increased by an average of five points (p<0.001), indicating an overall improvement in patient knowledge about asthma. The "Paru Sehat" application demonstrated significant potential in enhancing asthma knowledge across multiple domains. Further research is warranted to explore the long-term effectiveness of the application in diverse populations and settings, ultimately contributing to improved asthma management and patient outcomes.
- 17 April 2024
- Published by Narra Sains Indonesia in Narra J
- Vol. 4 (2) , e657
Open AccessRole of digital education through smartphones in improving knowledge among asthma patients: A preliminary study
Asthma is a chronic inflammatory airway disorder and is among the top ten causes of morbidity and mortality in Indonesia, highlighting the need for effective management strategies. This study aimed to evaluate changes in asthma knowledge levels before and after using the "Paru Sehat" smartphone application for digital education. A quasi-experimental study using a pre- and post-test design was conducted over three months at the outpatient clinic of Universitas Sumatera Utara Hospital, Medan, Indonesia, among asthma patients aged over 18 years. The patients completed the Patient Asthma Knowledge Questionnaire (PAKQ) before installing the "Paru Sehat" application to establish baseline knowledge. Once a week, patients received reminders to access materials covering an asthma overview, peak flow meter use, medication differences, and management techniques. After four weeks of intervention, the participants' knowledge was reassessed using the PAKQ. Data were analyzed using either paired Student's t-test or Wilcoxon test to assess the improvement in knowledge. The results showed increases in knowledge about asthma in general, asthma triggers, and asthma diagnosis domains, with the median score in each domain rising by one point (p=0.003, p=0.001, and p=0.002, respectively). The asthma management domain exhibited the largest change, with a median increase of two points (p<0.001). The total scores increased by an average of five points (p<0.001), indicating an overall improvement in patient knowledge about asthma. The "Paru Sehat" application demonstrated significant potential in enhancing asthma knowledge across multiple domains. Further research is warranted to explore the long-term effectiveness of the application in diverse populations and settings, ultimately contributing to improved asthma management and patient outcomes.
- Open Access
- 29 February 2024
- Published by Universitas Sumatera Utara in SCRIPTA SCORE Scientific Medical Journal
- Vol. 5 (2) , 105-112
Intervention Effect Between Smartphone and the Knowledge in Chronic Obstructive Pulmonary Disease Patients at Prof Chairuddin Panusunan Lubis General Hospital
Background: Health applications can assist in managing chronic patients such as Chronic Obstructive Pulmonary Disease (COPD). A smartphone application “Paru Sehat” is expected to help COPD patients increase their knowledge about the disease and its treatment. Objective: This study aims to examine the benefits of smartphone applications “Paru Sehat” on the level of knowledge of patients with the COPD about the disease and its treatment. Methods: A quasi-experimental studies were conducted in outpatient of stable COPD patients at Pulmonology and Respiratory Medicine Universitas Sumatera Utara Hospital. This research was conducted from March to June 2022. A questionnaire which elaborated question about COPD and its treatment were used to evaluate the level of knowledge of participants before and after 3 months of using smartphone application “Paru Sehat”. Results: From a sample of 38 COPD patients, the average knowledge level of COPD patients before using the “Paru Sehat” application as 5.125; after using the smartphone application, it was 8.5625. The hypothesis test shows that the value of p = 0.000, indicating an increase in the level of knowledge about COPD and its treatment. Out of 38 patients, all research subjects were male with the most age being 60 to 70 years old, having a history of heavy smoking and the highest level of severity of COPD 2. Conclusion: “Paru Sehat” application can influence the knowledge of COPD patients about their illness and treatment as well as the patient's independence in dealing with their illness. Keyword: COPD, level of patient knowledge, smarthphone application Latar Belakang: Aplikasi kesehatan dapat membantu dalam menangani pasien kronis seperti Penyakit Paru Obstruktif Kronik (PPOK). Aplikasi smartphone “Paru Sehat” diharapkan dapat membantu pasien PPOK meningkatkan pengetahuannya tentang penyakit dan pengobatannya. Tujuan: Penelitian ini bertujuan untuk menilai manfaat dari aplikasi smartphone “Paru Sehat” untuk tingkat pengetahuan pasien PPOK mengenai penyakit dan pengobatannya. Metode: Penelitian quasi eksperimental dilakukan pada pasien PPOK stabil rawat jalan di Pulmonologi dan Kedokteran Respirasi Rumah Sakit Universitas Sumatera Utara. Penelitian ini dilakukan antara bulan Maret 2022 hingga Juni 2022. Kuesioner yang berisi pertanyaan tentang PPOK dan pengobatannya digunakan untuk mengevaluasi tingkat pengetahuan peserta sebelum dan sesudah 3 bulan menggunakan aplikasi smartphone “Paru Sehat”. Hasil: Dari sampel 38 pasien PPOK, rata-rata tingkat pengetahuan pasien PPOK sebelum menggunakan aplikasi smartphone “Paru Sehat” adalah 5,125; setelah menggunakan aplikasi smartphone menjadi 8.5625. Uji hipotesis menunjukkan nilai p = 0,000 yang menunjukkan adanya peningkatan tingkat pengetahuan tentang PPOK dan pengobatannya. Dari 38 pasien, seluruh subjek penelitian berjenis kelamin laki-laki dengan usia terbanyak yaitu 60 hingga 70 tahun, memiliki riwayat perokok berat dan tingkat keparahan PPOK 2 tertinggi (GOLD 2). Kesimpulan: Aplikasi “Paru Sehat” dapat mempengaruhi pengetahuan pasien PPOK tentang penyakitnya dan pengobatannya serta kemandirian pasien dalam menghadapi penyakitnya. Kata Kunci: Aplikasi smartphone, PPOK, tingkat pengetahuan pasien
- 29 February 2024
- Published by Universitas Sumatera Utara in SCRIPTA SCORE Scientific Medical Journal
- Vol. 5 (2) , 105-112
Open AccessIntervention Effect Between Smartphone and the Knowledge in Chronic Obstructive Pulmonary Disease Patients at Prof Chairuddin Panusunan Lubis General Hospital
Background: Health applications can assist in managing chronic patients such as Chronic Obstructive Pulmonary Disease (COPD). A smartphone application “Paru Sehat” is expected to help COPD patients increase their knowledge about the disease and its treatment. Objective: This study aims to examine the benefits of smartphone applications “Paru Sehat” on the level of knowledge of patients with the COPD about the disease and its treatment. Methods: A quasi-experimental studies were conducted in outpatient of stable COPD patients at Pulmonology and Respiratory Medicine Universitas Sumatera Utara Hospital. This research was conducted from March to June 2022. A questionnaire which elaborated question about COPD and its treatment were used to evaluate the level of knowledge of participants before and after 3 months of using smartphone application “Paru Sehat”. Results: From a sample of 38 COPD patients, the average knowledge level of COPD patients before using the “Paru Sehat” application as 5.125; after using the smartphone application, it was 8.5625. The hypothesis test shows that the value of p = 0.000, indicating an increase in the level of knowledge about COPD and its treatment. Out of 38 patients, all research subjects were male with the most age being 60 to 70 years old, having a history of heavy smoking and the highest level of severity of COPD 2. Conclusion: “Paru Sehat” application can influence the knowledge of COPD patients about their illness and treatment as well as the patient's independence in dealing with their illness. Keyword: COPD, level of patient knowledge, smarthphone application Latar Belakang: Aplikasi kesehatan dapat membantu dalam menangani pasien kronis seperti Penyakit Paru Obstruktif Kronik (PPOK). Aplikasi smartphone “Paru Sehat” diharapkan dapat membantu pasien PPOK meningkatkan pengetahuannya tentang penyakit dan pengobatannya. Tujuan: Penelitian ini bertujuan untuk menilai manfaat dari aplikasi smartphone “Paru Sehat” untuk tingkat pengetahuan pasien PPOK mengenai penyakit dan pengobatannya. Metode: Penelitian quasi eksperimental dilakukan pada pasien PPOK stabil rawat jalan di Pulmonologi dan Kedokteran Respirasi Rumah Sakit Universitas Sumatera Utara. Penelitian ini dilakukan antara bulan Maret 2022 hingga Juni 2022. Kuesioner yang berisi pertanyaan tentang PPOK dan pengobatannya digunakan untuk mengevaluasi tingkat pengetahuan peserta sebelum dan sesudah 3 bulan menggunakan aplikasi smartphone “Paru Sehat”. Hasil: Dari sampel 38 pasien PPOK, rata-rata tingkat pengetahuan pasien PPOK sebelum menggunakan aplikasi smartphone “Paru Sehat” adalah 5,125; setelah menggunakan aplikasi smartphone menjadi 8.5625. Uji hipotesis menunjukkan nilai p = 0,000 yang menunjukkan adanya peningkatan tingkat pengetahuan tentang PPOK dan pengobatannya. Dari 38 pasien, seluruh subjek penelitian berjenis kelamin laki-laki dengan usia terbanyak yaitu 60 hingga 70 tahun, memiliki riwayat perokok berat dan tingkat keparahan PPOK 2 tertinggi (GOLD 2). Kesimpulan: Aplikasi “Paru Sehat” dapat mempengaruhi pengetahuan pasien PPOK tentang penyakitnya dan pengobatannya serta kemandirian pasien dalam menghadapi penyakitnya. Kata Kunci: Aplikasi smartphone, PPOK, tingkat pengetahuan pasien
- Open Access
- 15 February 2024
- Published by Perhimpunan Dokter Paru Indonesia in Respiratory Science
- Vol. 4 (2) , 139-147
Rare Case of Completely Healed Pneumomediastinum Due to Asthma Exacerbation in A Young Male Patient
Background: The term pneumomediastinum (PNM) refers to the presence of air within the mediastinal cavity. This illness is uncommon but can arise in adolescents with severe asthma attacks. In children aged 5 to 34, the incidence of pneumomediastinum after an acute asthma attack is 1 in 25,000. Men made up the majority of patients (76 percent of all cases). Pneumomediastinum can be diagnosed with the assistance of a chest CT scan. Case: A young man was diagnosed with pneumomediastinum due to an acute asthma attack in this case report. Symptoms of uncontrolled asthma include shortness of breath that worsens with wheezing, chest tightness, and a nonproductive cough. Since the age of 12, the patient in this instance has been receiving salbutamol inhalers. The physical examination revealed polyphonic lung respiration and subcutaneous crepitus in the neck, shoulders, and anterior chest. With adequate management of an asthma episode, pneumomediastinum recovers spontaneously, followed by recurrent symptomatic status, physical examination, and radiography examination. Discussion: Acute asthma exacerbations are one of the factors that can lead to spontaneous pneumomediastinum, in which mediastinal air can permeate the tissue and generate a pneumothorax, and if there is air in the subcutaneous area, it can lead to subcutaneous emphysema. Conclusion: Pneumomediastinum was a rare incidence, pulmonologists examining young adults with acute asthma exacerbations should evaluate for pneumomediastinum. In usual asthma therapy, a chest CT-scan is essential to screen for pneumomediastinum.
- 15 February 2024
- Published by Perhimpunan Dokter Paru Indonesia in Respiratory Science
- Vol. 4 (2) , 139-147
Open AccessRare Case of Completely Healed Pneumomediastinum Due to Asthma Exacerbation in A Young Male Patient
Background: The term pneumomediastinum (PNM) refers to the presence of air within the mediastinal cavity. This illness is uncommon but can arise in adolescents with severe asthma attacks. In children aged 5 to 34, the incidence of pneumomediastinum after an acute asthma attack is 1 in 25,000. Men made up the majority of patients (76 percent of all cases). Pneumomediastinum can be diagnosed with the assistance of a chest CT scan. Case: A young man was diagnosed with pneumomediastinum due to an acute asthma attack in this case report. Symptoms of uncontrolled asthma include shortness of breath that worsens with wheezing, chest tightness, and a nonproductive cough. Since the age of 12, the patient in this instance has been receiving salbutamol inhalers. The physical examination revealed polyphonic lung respiration and subcutaneous crepitus in the neck, shoulders, and anterior chest. With adequate management of an asthma episode, pneumomediastinum recovers spontaneously, followed by recurrent symptomatic status, physical examination, and radiography examination. Discussion: Acute asthma exacerbations are one of the factors that can lead to spontaneous pneumomediastinum, in which mediastinal air can permeate the tissue and generate a pneumothorax, and if there is air in the subcutaneous area, it can lead to subcutaneous emphysema. Conclusion: Pneumomediastinum was a rare incidence, pulmonologists examining young adults with acute asthma exacerbations should evaluate for pneumomediastinum. In usual asthma therapy, a chest CT-scan is essential to screen for pneumomediastinum.
- Open Access
- 30 January 2024
- Published by Universitas Airlangga in Jurnal Respirasi
- Vol. 10 (1) , 36-41
Effects of Upper Arm and Breathing Exercise on Interleukin-6 in COVID-19 Patients
Introduction: COVID-19 disease has become a comprehensive world issue and has been declared a significant threat to global health. Interleukin-6 (IL-6) is an important inflammatory marker and one of the triggers of the cytokine storm in COVID-19, where increased levels can be an independent predictor of COVID-19 mortality. This study aimed to observe the effect of upper arm and breathing exercises on IL-6 levels in severe COVID-19 patients. Methods: The study design was quasi-experimental, with blood tests conducted before and after the examination. A total of 20 patients with confirmed COVID-19 were involved, divided into intervention and control groups. Results: Blood tests to determine baseline IL-6 levels were performed in all patients. Patients from the intervention group were given upper arm and breathing exercises for ten days, twice a day, via video tutorials on mobile phones, while patients from the control group did not receive any exercises. Patients from the intervention group obtained mean pre- and post-exercise IL-6 levels of 42.38 ± 48.48 and 16.78 ± 18.29, respectively (p = 0.005). Conclusion: Upper arm and breathing exercises showed significant changes in IL-6 levels in severe COVID-19 patients.
- 30 January 2024
- Published by Universitas Airlangga in Jurnal Respirasi
- Vol. 10 (1) , 36-41
Open AccessEffects of Upper Arm and Breathing Exercise on Interleukin-6 in COVID-19 Patients
Introduction: COVID-19 disease has become a comprehensive world issue and has been declared a significant threat to global health. Interleukin-6 (IL-6) is an important inflammatory marker and one of the triggers of the cytokine storm in COVID-19, where increased levels can be an independent predictor of COVID-19 mortality. This study aimed to observe the effect of upper arm and breathing exercises on IL-6 levels in severe COVID-19 patients. Methods: The study design was quasi-experimental, with blood tests conducted before and after the examination. A total of 20 patients with confirmed COVID-19 were involved, divided into intervention and control groups. Results: Blood tests to determine baseline IL-6 levels were performed in all patients. Patients from the intervention group were given upper arm and breathing exercises for ten days, twice a day, via video tutorials on mobile phones, while patients from the control group did not receive any exercises. Patients from the intervention group obtained mean pre- and post-exercise IL-6 levels of 42.38 ± 48.48 and 16.78 ± 18.29, respectively (p = 0.005). Conclusion: Upper arm and breathing exercises showed significant changes in IL-6 levels in severe COVID-19 patients.